Purpose: In the present study, antitubercular activities and in silico physicochemical toxicities and bioactivity profile of some 3-chloro-6-arylpyridazines (3a-d) and 6-aryl-4,5-dihydropyridazine-3(2H)-thiones (4a-d) are studied. 
INTRODUCTION
Pyridazine is an important six member heterocyclic compound containing two nitrogen hetero atoms at 1 and 2 positions in the ring. Recently, there has been an increased interest in the pyridazine compounds because these compounds showed almost all types of pharmacological activities such as antimicrobial, antibacterial, antifungal, antiviral, analgesic, anti-inflammatory, antifeedant, antidiabetic, herbicidal, antiplatelet, anticancer, antitubercular, antidepressant, antithrombotic, diuretics, anti-HIV, antipyretics, cardio-tonic, antihypertensive, anticonvulsant, anti-asthamatic, antidepressant, anxiolytic and other anticipated activities. It is also used as chemical intermediates for drugs synthesis and agrochemicals. [1] [2] [3] Various pyridazinone and thiopyridazinones derivatives were synthesized and their anti-TB activity was tested. [4] [5] [6] Hence this feature of the ring system was tapped for the presence of any anti-TB activity. Drug resistance is a major public health problem that threatens progress made in TB care and control worldwide. Multidrug resistant tuberculosis (MDR-TB) is a form of TB that is resistant to two or more of the primary drugs like isoniazid (INH) and rifampin (RIF) used for the treatment of TB. The WHO estimated that there were about 310,000 cases of MDR-TB worldwide in 2011. 7 New drug synthesis is required to fight against MDR-TB strain. Majority of the synthesized drugs fails because of inadequate information about their (absorption, distribution, metabolism and excretions) (ADME), toxicity and bioactivity profile. In the present study we designed and synthesized some pyridazine (3a-d and 4a-d) compounds on the basis of their physicochemical parameter ADME, toxicity and bioactivity profiles by the help of online in silico software Molinspiron and ADMET SAR. 8, 9 All synthesized compounds were evaluated their anti-TB activity by using Microplate Alamar Blue (MABA) test.
MATERIALS AND METHOD

Structure designing, physico-chemical property and bioactivity prediction software
In present study structure was designed by Med Chem Designer software. Physicochemical property and bioactivity prediction study was done by help of online software Molinspiration.
8 ADME and toxicity was predicted by ADMET SAR online tool.
9
In silico physico-chemical property prediction
Molinspiration provides a wide range of software tools by which we predict intestinal absorption property in compliance with Lipinski's rule-of-five. "Rule-of-five" is set of simple molecular descriptors used by Lipinski in formulating his "Rule-of-five". 7 The rule states, that most "drug-like" molecules have logP <=5, molecular weight <=500 daltons, number of hydrogen bond acceptors <=10, and number of hydrogen bond donors <=5. Molecules violating more than one of these rules may have problems with bioavailability. Physicochemical parameters play a vital role in generation and escalation of bioactivity of chemical entity. Molinspiration, web based software was used to obtain parameter such as Log P, TPSA, drug likeness. LogP (Octanol-water partition coefficient) is used in QSAR studies and rational drug design as a measure of molecular hydrophobicity. 8 Hydrophobicity affects drug absorption, bioavailability, hydrophobic drug-receptor interactions, metabolism of molecules, as well as their toxicity. LogP (octanol/ water partition coefficient) is calculated by the methodology developed by Molinspiration as a sum of fragment based contributions and correction factors and used to predict the permeability of molecule across the cell membrane. Topological polar surface area (TPSA) is a very useful parameter for prediction of drug transport properties. Polar surface area is defined as a sum of surfaces of polar atoms (usually oxygens, nitrogens and attached hydrogens) in a molecule. This parameter has been shown to correlate very well with the human intestinal absorption, Caco-2 mono layers permeability, and blood-brain barrier penetration. Molecular Polar Surface Area (MPSA) is calculated based on the methodology published by Ertl et al (include a reference, instead)
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as a sum of fragment based contributions in which Oand N-centered polar fragments are to be considered and calculated by surface areas that are occupied by oxygen, nitrogen atoms and by hydrogen atoms attached to them. 10, 11 Molecular volume (MV) determines transport characteristics of molecules, such as intestinal absorption or blood-brain barrier penetration. Volume is therefore often used in QSAR studies to model molecular properties and biological activity. Method for calculation of MV developed at Molinspiration is based on group contributions. Number of Rotatable Bonds (nrotb) is a simple topological parameter that measures molecular flexibility. It has been shown to be a very good descriptor of oral bioavailability of drugs. 11, 12 Rotatable bond is defined as any single non-ring bond, bounded to nonhydrogen atom. All the above mentioned results were compared with standard reference.
In silico ADME and Toxicity prediction
In silico ADME and toxicity prediction was accomplished by the help of ADMET SAR on line tool provides the latest and most comprehensive manually accumulated data for diverse chemicals associated with known Absorption, Distribution, Metabolism, Excretion and Toxicity profiles.
13,14
In silico Bioactivity prediction
The drugs were also checked for the bioactivity by calculating the activity score for different molecular target like GPCR (G-protein coupled receptor) ligand, ion channel modulator, kinase inhibitor, nuclear receptor ligand. All the parameters were checked with the help of software Molinspiration drug-likeness score online. 8 
General Procedure for Synthesis
3-chloro-6-aryl-4,5-dihydropyridazines (3a-d) and 6-aryl-4,5-dihydropyridazine-3(2H)-thiones (4a-d)
All these compounds (3a-3d) and (4a-4d) were previously synthesized by following methods. [15] [16] [17] Compounds 3a-d were formed by reaction of compounds 
3-chloro-6-aryl-4,5-dihydropyridazine (3a-d)
A mixture of compound 2a (0.01 mol) and phosphorous oxychloride (POCl3) (20 mL), was heated on a steam bath for 6 h. After heating, the mixture was poured on crushed ice and made alkaline by addition of sodium bicarbonate. Crude 3-chloropyridazine was collected by filtration.
All the remaining acids were synthesized by analogous procedure with minor modification in temperature of reaction and use of nitrobenzene as a solvent.
6-Aryl-4,5-dihydropyridazine-3(2H)-thione (4a-d)
Compounds (4a-d) were prepared by refluxing 0.1 mole of (2a-d) dissolved in xylene, with phosphorus pentasulphide (0.1 mol) for 4 hours at a temperature of 150º. The contents were poured into a beaker and concentrated to a small volume. Yellow colored crystals were collected, crystallized from ethanol and dried at room temperature. The two groups of compounds were obtained as a result of condensation with hydrazine hydrate of aroyl propionic acid and substitution with sulphur.
6-phenyl-4,5-dihydropyridazine-3(2H)-thione
Anti-TB activity by using Microplate Alamar Blue Dye (MABA) test
The anti-TB activities of synthetic compounds (3a-d and 4a-d) were assessed against M. tuberculosis using microplate Alamar Blue Assay (MABA). Briefly, 200 µl of sterile de-ionized water was added to all outer perimeter wells of sterile 96 wells plate to minimize evaporation of medium in the test wells during incubation. The 96 wells plate received 100 µl of the Middle brook 7H9 broth and serial dilution of compounds was made directly on plate. The final drug concentrations 3a-d and 4a-d tested were 100 to 0.2 µg/ml. Plates were sealed with parafilm and incubated at 37º for five days.
After this time, 25 µl of freshly prepared 1:1 mixture of Almar Blue reagent and 10% tween 80 was added to the plate and incubated for 24 hrs. A blue color in the well was interpreted as no bacterial growth, and pink color was scored as growth. The MIC was defined as lowest drug concentration which prevented the color change from blue to pink.
RESULTS AND DISCUSSION
The results of physicochemical properties (Drug-like properties) of the compounds (3a-d and 4a-d) are shown in the Table 1 . Physicochemical parameters were compared with reference standards. Isoniazid (INH), Streptomycin (STR) and Pyrazinamide (PZA) were used as standard. Oral dosing is still most preferable route for drug administration and therefore to get optimum therapeutic efficacy, intestinal absorption of the drug is the first criteria to be considered. Lipinski's "rule-of-five"-identified some critical property maintained precisely the general requirement for absorption of drug molecule. LogP, TPSA, MW, nON, nOHNH, nviolation, nrotb, MV data revealed that all the synthesized compounds (3a-d and 4a-d) possess "drugs like property" and complying "rule-of-five". Hence all compounds may exhibit optimum absorption and bioavailability. For accurate and effective prediction of intestinal absorption, several in vitro methods have been developed. Among them, the most popular cellbased model for intestinal permeability is the Caco-2 cell system. 10, 11 Caco-2 cell permeability, human intestinal absorption and blood brain barrier penetration data further support optimum absorption and distribution possibility of the synthesized compounds. P-glycoprotein (P-gp) activity in the apical cell membrane may limit the bioavailability of the drug molecule. 18, 19 Result revealed that all the compounds were neither substrate nor the inhibitor of p-gp Table 2 . ADME and Toxicity predictions are presented in the Table 3-5. Cytochrome P450 (CYP) enzymes are important enzymes for drug metabolism. The CYP enzymes are a family of heme proteins involved in the metabolism of numerous pharmacologically active compounds and can cause drugdrug-interactions with co-administered drugs as well as unwanted adverse side effects. 20 In silico data indicate the entire designed compounds cannot metabolize (non substrate) by CYP 450 2C9, CYP 450 2D6, and CYP 450 3A4 enzymes. All designed drugs are inhibitor of CYP prediction of compounds (3a-d and 4a-d (Table 2) . Pyridazinone compounds (3a-d and 4a-d) are described in this study, and a reaction sequence for the preparation is outlined in Figure 1 (3a-d) . The 6-aryl-4,5-dihydro pyridazines (2a-d) followed by substitution with sulphur by reaction with phosphorus pentasulphite to yield the compounds (4a-d). All the final compounds were structurally confirmed on the basis of NMR and IR spectral data, (explanation of the procedure is not necessary, discuss only the results) and the final synthesized compounds were evaluated for anti-TB activity. All the compounds 3a-d and 4a-d were screened for anti-TB activity. The anti-TB activity was evaluated by the MABA test. Out of the ten compounds subjected to anti-TB screening by the MABA method and showed significant activity. The result indicate that MIC of compound 4a-d and 3a is 6.25 µg/ml, potent than compound 3b-d with MIC 12.5 µg/ ml and results are represented in the Table 6 . 
CONCLUSION
From present study entire designed compounds fulfill the parameter to become a "drug like" molecule, having absorption property through human intestine (HIA + ), Caco-2 cell and can penetrate blood brain barrier (BBB + ) and non-inhibitor and non-substrate to p-gp. All compounds are inhibitor of CYP 450 1A2 and compound 4a-d are inhibitor of CYP 450 2C9, CYP 450 2D6, CYP 450 2C19, and CYP 450 3A4. Compound 4a-d can cause drug-drug interaction with co-administered drug metabolized by the enzymes. All the drugs were non mutagenic, non-carcinogenic and LD50 value more than PZA. Compound 4a-d are better enzyme inhibition score and compound 3b-d are better ligand for GPCR receptor except 3a. From anti-tubercular activity study result indicate that compounds 4a-d having sulfur group in their side chain are more potent anti-TB compound than compounds having chlorine group in their side chain (except compound 3a). Results indicated that pyridazine compound with sulfur groups (4a-d) were more potent anti-TB agents than compounds containing chlorine (3b-d, except 3a) group at their side chain. Pyridazines are noteworthy for their physiological and biological importance. Medicinal chemists are working on pyridazines due to their wide range of biological activities. A further extensive study is required to explore other biological potential of pyridazines.
